Fengxin Lu

1.5k total citations
18 papers, 834 citations indexed

About

Fengxin Lu is a scholar working on Rheumatology, Hematology and Immunology. According to data from OpenAlex, Fengxin Lu has authored 18 papers receiving a total of 834 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Rheumatology, 8 papers in Hematology and 7 papers in Immunology. Recurrent topics in Fengxin Lu's work include Complement system in diseases (7 papers), Rheumatoid Arthritis Research and Therapies (6 papers) and Coagulation, Bradykinin, Polyphosphates, and Angioedema (5 papers). Fengxin Lu is often cited by papers focused on Complement system in diseases (7 papers), Rheumatoid Arthritis Research and Therapies (6 papers) and Coagulation, Bradykinin, Polyphosphates, and Angioedema (5 papers). Fengxin Lu collaborates with scholars based in United States and Germany. Fengxin Lu's co-authors include Alvin E. Davis, Pedro Mejia, Stacey M. Fernandes, Daniel H. Solomon, Yvonne Lee, Penny Wang, Jeffrey A. Sparks, Dongxu Liu, Gangjian Qin and Kathleen M.M. Vanni and has published in prestigious journals such as The Journal of Immunology, The Journal of Infectious Diseases and Annals of the Rheumatic Diseases.

In The Last Decade

Fengxin Lu

18 papers receiving 815 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Fengxin Lu United States	14	293	203	202	169	94	18	834
Samuel H. Pepkowitz United States	20	379 1.3×	222 1.1×	224 1.1×	92 0.5×	197 2.1×	54	1.5k
Katalin Rajczy Hungary	15	281 1.0×	74 0.4×	100 0.5×	66 0.4×	79 0.8×	54	705
Neil A. Lachant United States	16	99 0.3×	215 1.1×	334 1.7×	74 0.4×	116 1.2×	51	990
António Marinho Portugal	22	429 1.5×	58 0.3×	180 0.9×	357 2.1×	228 2.4×	92	1.3k
Grant C. Hughes United States	12	558 1.9×	35 0.2×	191 0.9×	234 1.4×	244 2.6×	24	1.1k
JOHN STAIGE DAVIS United States	19	285 1.0×	91 0.4×	117 0.6×	254 1.5×	169 1.8×	59	1.1k
Oriano Radillo Italy	19	612 2.1×	78 0.4×	84 0.4×	125 0.7×	140 1.5×	51	1.1k
Han Joo Baek South Korea	17	298 1.0×	38 0.2×	180 0.9×	583 3.4×	116 1.2×	68	997
Ali Jawad United Kingdom	18	467 1.6×	33 0.2×	106 0.5×	449 2.7×	176 1.9×	64	1.1k
J. R. Kalden Germany	19	732 2.5×	88 0.4×	330 1.6×	964 5.7×	164 1.7×	57	1.7k

Countries citing papers authored by Fengxin Lu

Since Specialization

Citations

This map shows the geographic impact of Fengxin Lu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Fengxin Lu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Fengxin Lu more than expected).

Fields of papers citing papers by Fengxin Lu

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Fengxin Lu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Fengxin Lu. The network helps show where Fengxin Lu may publish in the future.

Co-authorship network of co-authors of Fengxin Lu

This figure shows the co-authorship network connecting the top 25 collaborators of Fengxin Lu. A scholar is included among the top collaborators of Fengxin Lu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Fengxin Lu. Fengxin Lu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

18 of 18 papers shown

Solomon, Daniel H., Jon T. Giles, Katherine P. Liao, et al.. (2022). Reducing cardiovascular risk with immunomodulators: a randomised active comparator trial among patients with rheumatoid arthritis. Annals of the Rheumatic Diseases. 82(3). 324–330. 43 indexed citations

Lee, Yvonne, Fengxin Lu, Penny Wang, et al.. (2021). Outcomes of a Mobile App to Monitor Patient‐Reported Outcomes in Rheumatoid Arthritis: A Randomized Controlled Trial. Arthritis & Rheumatology. 73(8). 1421–1429. 24 indexed citations

Giles, Jon T., Pamela M. Rist, Katherine P. Liao, et al.. (2021). Testing the Effects of Disease‐Modifying Antirheumatic Drugs on Vascular Inflammation in Rheumatoid Arthritis: Rationale and Design of the TARGET Trial. ACR Open Rheumatology. 3(6). 371–380. 11 indexed citations

Vanni, Kathleen M.M., Nancy Berliner, Nina P. Paynter, et al.. (2020). Adverse Effects of Low‐Dose Methotrexate in a Randomized Double‐Blind Placebo‐Controlled Trial: Adjudicated Hematologic and Skin Cancer Outcomes in the Cardiovascular Inflammation Reduction Trial. ACR Open Rheumatology. 2(12). 697–704. 21 indexed citations

Lee, Yvonne, et al.. (2020). Patient adherence with a smartphone app for patient-reported outcomes in rheumatoid arthritis. Lara D. Veeken. 60(1). 108–112. 37 indexed citations

Solomon, Daniel H., et al.. (2019). THU0155 PATIENT ADHERENCE WITH A SMARTPHONE APP FOR DISEASE MONITORING IN RHEUMATOID ARTHRITIS. Annals of the Rheumatic Diseases. 78. 350–351. 3 indexed citations

Wang, Penny, et al.. (2018). A Novel Mobile App and Population Management System to Manage Rheumatoid Arthritis Flares: Protocol for a Randomized Controlled Trial. JMIR Research Protocols. 7(4). e84–e84. 10 indexed citations

Kim, Seoyoung C., Marcelo F. Di Carli, Rajesh Garg, et al.. (2018). Asymptomatic hyperuricemia and coronary flow reserve in patients with metabolic syndrome. BMC Rheumatology. 2(1). 17–17. 7 indexed citations

Wang, Penny, et al.. (2018). Mobile Apps for Individuals With Rheumatoid Arthritis. JCR Journal of Clinical Rheumatology. 25(3). 133–141. 48 indexed citations

10.

Wang, Penny, Stacy E. Smith, Rajesh Garg, et al.. (2018). Identification of monosodium urate crystal deposits in patients with asymptomatic hyperuricemia using dual-energy CT. RMD Open. 4(1). e000593–e000593. 33 indexed citations

11.

Sparks, Jeffrey A., Medha Barbhaiya, Elizabeth W. Karlson, et al.. (2017). Investigating methotrexate toxicity within a randomized double-blinded, placebo-controlled trial: Rationale and design of the Cardiovascular Inflammation Reduction Trial-Adverse Events (CIRT-AE) Study. Seminars in Arthritis and Rheumatism. 47(1). 133–142. 29 indexed citations

12.

Mejia, Pedro, Monica Diez-Silva, Faustin Kamena, et al.. (2015). Human C1-Inhibitor Suppresses Malaria Parasite Invasion and Cytoadhesion via Binding to Parasite Glycosylphosphatidylinositol and Host Cell Receptors. The Journal of Infectious Diseases. 213(1). 80–89. 17 indexed citations

13.

Lu, Fengxin, Stacey M. Fernandes, & Alvin E. Davis. (2012). The effect of C1 inhibitor on myocardial ischemia and reperfusion injury. Cardiovascular Pathology. 22(1). 75–80. 33 indexed citations

14.

Lu, Fengxin, Pedro Mejia, & Alvin E. Davis. (2010). C1 inhibitor, a multi-functional serine protease inhibitor. Thrombosis and Haemostasis. 104(11). 886–893. 186 indexed citations

15.

Lu, Fengxin, Stacey M. Fernandes, & Alvin E. Davis. (2010). The role of the complement and contact systems in the dextran sulfate sodium-induced colitis model: the effect of C1 inhibitor in inflammatory bowel disease. American Journal of Physiology-Gastrointestinal and Liver Physiology. 298(6). G878–G883. 31 indexed citations

16.

Lu, Fengxin, Anil K. Chauhan, Stacey M. Fernandes, et al.. (2008). The effect of C1 inhibitor on intestinal ischemia and reperfusion injury. American Journal of Physiology-Gastrointestinal and Liver Physiology. 295(5). G1042–G1049. 21 indexed citations

17.

Davis, Alvin E., Pedro Mejia, & Fengxin Lu. (2008). Biological activities of C1 inhibitor. Molecular Immunology. 45(16). 4057–4063. 234 indexed citations

18.

Liu, Dongxu, Fengxin Lu, Gangjian Qin, et al.. (2007). C1 Inhibitor-Mediated Protection from Sepsis. The Journal of Immunology. 179(6). 3966–3972. 46 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact